Pure Global AI
NCT06293222Recruitment Completed

Patient and Public Involvement and Engagement in Research With Children and Young People With Sickle Cell Disorder and Their Families

Patient and Public Involvement and Engagement in Research on Life-limiting Conditions With Children and Young People With Sickle Cell Disorder and Their Families
King's College LondonClinicalTrials.gov
Study focus
Disease/Condition
Sickle Cell Disease
Study type
Observational
Sponsor & location
Primary sponsor
King's College London
Location
London, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Aug 21, 2023
End date
Apr 30, 2024
Enrollment
20 participants
Primary outcome

Workshops with participants to develop resources that enable children and young people with sickle cell disorder and their families to engage in research

Summary

Aim: To co-produce resources for inclusive and equitable Patient and Public Involvement and
 Engagement in research on life-limiting conditions, with children and young people with
 sickle cell disorder and their families.
 
 Methods: Workshops with a) members of a patient advocacy organisation (Sickle Cell Society
 n=5) b): i) Children and young people (10-18 years) with sickle cell disorder (n=15) and ii)
 their siblings (10-18 years, n=10) and iii) their parents (n=15), c) Researchers form the
 Cicely Saunders Institute Outputs: Resources that enable children and young people with
 sickle cell disorder and their families to engage in research

ICD-10 classifications
Sickle-cell disordersOther sickle-cell disordersSickle-cell traitSickle-cell anaemia with crisisSickle-cell anaemia without crisis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06293222
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06293222 through Pure Global AI's free database. This phase not specified trial is sponsored by King's College London and is currently Recruitment Completed. The study focuses on Sickle Cell Disease. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.